CA51228/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1993	2
1994	2
1995	2
1996	2
1998	1
1999	1
2000	2
2001	2
2002	4
2003	5
2004	2
2025	0

1

Mechanisms of drug resistance in ovarian cancer.

Johnson SW, Ozols RF, Hamilton TC. Johnson SW, et al. Cancer. 1993 Jan 15;71(2 Suppl):644-9. doi: 10.1002/cncr.2820710224. Cancer. 1993. PMID: 8420689 Review.

2

The role of molecular biology in understanding ovarian cancer initiation and progression.

Bingham C, Roberts D, Hamilton TC. Bingham C, et al. Int J Gynecol Cancer. 2001;11 Suppl 1:7-11. doi: 10.1046/j.1525-1438.2001.11(suppl.1)sup1007.x. Int J Gynecol Cancer. 2001. PMID: 11488996 Review.

3

Vascular endothelial growth factor in ovarian cancer.

Hazelton DA, Hamilton TC. Hazelton DA, et al. Curr Oncol Rep. 1999 Sep;1(1):59-63. doi: 10.1007/s11912-999-0011-9. Curr Oncol Rep. 1999. PMID: 11122799 Review.

4

The biology of ovarian cancer.

Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC. Auersperg N, et al. Semin Oncol. 1998 Jun;25(3):281-304. Semin Oncol. 1998. PMID: 9633841 Review.

5

Pathology of Ovarian Neoplasms in Genetically Modified Mice.

Nikitin AY, Connolly DC, Hamilton TC. Nikitin AY, et al. Comp Med. 2004 Feb;54(1):26-8. Comp Med. 2004. PMID: 15382342 Review. No abstract available.

6

Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines.

Johnson SW, Shen D, Pastan I, Gottesman MM, Hamilton TC. Johnson SW, et al. Exp Cell Res. 1996 Jul 10;226(1):133-9. doi: 10.1006/excr.1996.0211. Exp Cell Res. 1996. PMID: 8660948

7

Activation of cancer-specific gene expression by the survivin promoter.

Bao R, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA, Hamilton TC. Bao R, et al. J Natl Cancer Inst. 2002 Apr 3;94(7):522-8. doi: 10.1093/jnci/94.7.522. J Natl Cancer Inst. 2002. PMID: 11929953

8

Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

Selvakumaran M, Pisarcik DA, Bao R, Yeung AT, Hamilton TC. Selvakumaran M, et al. Cancer Res. 2003 Mar 15;63(6):1311-6. Cancer Res. 2003. PMID: 12649192

9

Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium.

Roberts D, Williams SJ, Cvetkovic D, Weinstein JK, Godwin AK, Johnson SW, Hamilton TC. Roberts D, et al. DNA Cell Biol. 2002 Jan;21(1):11-9. doi: 10.1089/10445490252810276. DNA Cell Biol. 2002. PMID: 11879576

10

Mouse models of human cancers (Part 2).

Galvez JJ, Cardiff RD, Munn RJ, Borowsky AD. Galvez JJ, et al. Comp Med. 2004 Feb;54(1):13-5. Comp Med. 2004. PMID: 15027614 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year